References
- van de Merwe JP, Nordling J, Bouchelouche P, Bouchelouche K, Cervigni M, Daha LK, Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol 2008;53:60–7.
- Moncada S. Nitric oxide in the vasculature: physiology and pathophysiology. Ann N Y Acad Sci 1997;811:60–7; discussion 7–9.
- Aranda E, Lopez-Pedrera C, De La Haba-Rodriguez JR, Rodriguez-Ariza A. Nitric oxide and cancer: the emerging role of S-nitrosylation. Curr Mol Med 2012;12:50–67.
- Lundberg JO, Ehren I, Jansson O, Adolfsson J, Lundberg JM, Weitzberg E, Elevated nitric oxide in the urinary bladder in infectious and noninfectious cystitis. Urology 1996;48:700–2.
- Logadottir Y, Ehren I, Fall M, Wiklund NP, Peeker R. Intravesical nitric oxide production discriminates between classic and nonulcer interstitial cystitis. J Urol 2004;171:1148–50; discussion 50–1.
- Lirk P, Hoffmann G, Rieder J. Inducible nitric oxide synthase – time for reappraisal. Curr Drug Targets Inflamm Allergy 2002;1:89–108.
- Koskela LR, Thiel T, Ehren I, De Verdier PJ, Wiklund NP. Localization and expression of inducible nitric oxide synthase in biopsies from patients with interstitial cystitis. J Urol 2008;180:737–41.
- Unkeless JC.. Human Fc receptors for IgG. Int Rev Immunol 1989;5:165–71.
- Johansson SL, Fall M. Clinical features and spectrum of light microscopic changes in interstitial cystitis. J Urol 1990;143:1118–24.
- Lynes WL, Flynn SD, Shortliffe LD, Lemmers M, Zipser R, Roberts LD, Mast cell involvement in interstitial cystitis. J Urol 1987;138:746–52.
- Sugiura H, Ichinose M. Nitrative stress in inflammatory lung diseases. Nitric Oxide 2011;25:138–44.
- Gillenwater JY, Wein AJ. Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28–29, 1987. J Urol 1988;140:203–6.
- Kunisch E, Fuhrmann R, Roth A, Winter R, Lungershausen W, Kinne RW. Macrophage specificity of three anti-CD68 monoclonal antibodies (KP1, EBM11, and PGM1) widely used for immunohistochemistry and flow cytometry. Ann Rheum Dis 2004;63:774–84.
- Ehren I, Hosseini A, Herulf M, Lundberg JO, Wiklund NP. Measurement of luminal nitric oxide in bladder inflammation using a silicon balloon catheter: a novel minimally invasive method. Urology 1999;54:264–7.
- Kim SE, Shin MS, Kim CJ, Park JH, Chung KJ, Jung H, Effects of tamsulosin on urinary bladder function and neuronal activity in the voiding centers of rats with cyclophosphamide-induced overactive bladder. Int Neurourol J 2012;16:13–22.
- Richter B, Roslind A, Hesse U, Nordling J, Johansen JS, Horn T, YKL-40 and mast cells are associated with detrusor fibrosis in patients diagnosed with bladder pain syndrome/interstitial cystitis according to the 2008 criteria of the European Society for the Study of Interstitial Cystitis. Histopathology 2010;57:371–83.
- Erickson DR, Belchis DA, Dabbs DJ. Inflammatory cell types and clinical features of interstitial cystitis. J Urol 1997;158:790–3.
- Christmas TJ, Bottazzo GF. Abnormal urothelial HLA-DR expression in interstitial cystitis. Clin Exp Immunol 1992;87:450–4.